Turning 65 soon? These 5 tips can help make applying for Medicare easier so you can continue to get the cancer care you need.

What is access to cancer care like in the Philippines? Medical oncologist Ann Meredith Garcia Trinidad shares her experiences and insights.

The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include an effective medication for metastatic prostate cancer, targeted therapy that slows the growth of metastatic pancreatic cancer, how socioeconomic factors may affect survival for multiple myeloma, and how the ACA resulted in earlier treatment and improved equality in care.

Health insurance for cancer treatment can be less overwhelming by taking some simple steps.

Survivor and advocate Florence Kurttila describes her key takeaways from the 2019 Gastrointestinal Cancers Symposium.

Laredo, Texas, was ASCO President Dr. Bertagnolli’s latest stop in her ASCO in the Community tour. These visits are focused on understanding and addressing the barriers that prevent people from receiving quality cancer care. Local medical oncologist Dr. Eduardo Miranda shares what patients, caregivers, and health care providers in his community had to say.

ASCO has released the results of its second National Cancer Opinion Survey. Learn how Americans view alternative treatments, which Americans worry most about paying for and getting cancer care, and whether Americans feel people with cancer should have access to opioids.

Research highlights from the meeting include new details on the use of opioids in cancer care and the burdens of the cost of care.

Wrapping up this year’s Research Round Up podcast series, Cancer.Net Associate Editors share news and research from the 2018 ASCO Annual Meeting.

Oncology professionals from around the globe are at the 2018 ASCO Annual Meeting. Today’s key research highlights include the effects of geriatric assessment on patient-doctor communication, treatments for advanced prostate cancer that may work better in black men, the possibility that women are undertreated for head and neck cancer, and a comparison of treatment costs for colorectal cancer between the U.S. and Canada.